KUALA LUMPUR – Pharmaniaga Bhd’s shares on Bursa Malaysia rose in the early session today after the group announced that its unit signed an additional Covid-19 vaccine supply agreement with the government yesterday.
At 9.52am, the counter rose from 1.0 sen to 92 sen with 9.12 million shares traded.
The group’s wholly owned subsidiary, Pharmaniaga Lifescience Sdn Bhd (PLS), has signed the letter of acceptance (additional) for the procurement of supply of the Covid-19 Coronavac Suspension vaccine involving an additional six million doses of fill-and-finish and imported finished product.
In a filing with Bursa yesterday, Pharmaniaga said the parties have also agreed to execute a supplementary agreement to enable PLS to sell, supply and deliver to the government the number of doses requested.
Pharmaniaga said the contract will have a material effect on the group’s earnings and earnings per share for the financial year ending December 31. – Bernama, August 13, 2021
